<?xml version="1.0" encoding="UTF-8"?>
<!-- このサイトマップは、2026年7月27日の6:44 AMに、WordPress 用のオリジナル SEO プラグイン All in One SEO v4.6.5により動的生成されました。 -->

<?xml-stylesheet type="text/xsl" href="https://czeek.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>CzeekV インデックス</title>
		<link><![CDATA[https://czeek.com]]></link>
		<description><![CDATA[CzeekV インデックス]]></description>
		<lastBuildDate><![CDATA[Sun, 26 Jul 2026 14:10:31 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://czeek.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://czeek.com/information-889/]]></guid>
			<link><![CDATA[https://czeek.com/information-889/]]></link>
			<title>論文・技術情報追加のお知らせ</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 14:10:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/association-of-autosomal-dominant-polycystic-kidney-disease-with-incident-aortic-dissection-or-aneurysm/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/association-of-autosomal-dominant-polycystic-kidney-disease-with-incident-aortic-dissection-or-aneurysm/]]></link>
			<title>Association of Autosomal Dominant Polycystic Kidney Disease With Incident Aortic Dissection or Aneurysm.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/association-between-ramelteon-use-and-risk-of-fragility-fractures-a-retrospective-cohort-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/association-between-ramelteon-use-and-risk-of-fragility-fractures-a-retrospective-cohort-study/]]></link>
			<title>Association between ramelteon use and risk of fragility fractures: A retrospective cohort study.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/persistence-of-romosozumab-vs-teriparatide-in-japanese-older-adults-aged-75-years-with-osteoporosis-a-population-based-cohort-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/persistence-of-romosozumab-vs-teriparatide-in-japanese-older-adults-aged-75-years-with-osteoporosis-a-population-based-cohort-study/]]></link>
			<title>Persistence of romosozumab vs. teriparatide in Japanese older adults aged &gt;/= 75 years with osteoporosis: a population-based cohort study.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/smartphone-cbt-engagement-and-depressive-symptoms-secondary-analysis-of-the-resilient-trial-using-a-time-varying-exposure-approach/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/smartphone-cbt-engagement-and-depressive-symptoms-secondary-analysis-of-the-resilient-trial-using-a-time-varying-exposure-approach/]]></link>
			<title>Smartphone CBT engagement and depressive symptoms: secondary analysis of the RESiLIENT trial using a time-varying exposure approach.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/time-vs-step-based-physical-activity-metrics-for-health/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/time-vs-step-based-physical-activity-metrics-for-health/]]></link>
			<title>Time- vs Step-Based Physical Activity Metrics for Health.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/comparative-cardiovascular-effectiveness-of-glp-1ras-versus-dpp-4is-in-dialysis-patients-with-type-2-diabetes-a-target-trial-emulation/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/comparative-cardiovascular-effectiveness-of-glp-1ras-versus-dpp-4is-in-dialysis-patients-with-type-2-diabetes-a-target-trial-emulation/]]></link>
			<title>Comparative cardiovascular effectiveness of GLP-1RAs versus DPP-4is in dialysis patients with type 2 diabetes: a target trial emulation.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/early-adoption-of-lecanemab-in-japan-december-2023-december-2024-pretreatment-diagnostic-timelines-from-the-desc-claims-database/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/early-adoption-of-lecanemab-in-japan-december-2023-december-2024-pretreatment-diagnostic-timelines-from-the-desc-claims-database/]]></link>
			<title>Early adoption of lecanemab in Japan (December 2023-December 2024): Pretreatment diagnostic timelines from the DeSC claims database.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/insomnia-and-the-risk-of-atrial-fibrillation-a-nationwide-real-world-cohort-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/insomnia-and-the-risk-of-atrial-fibrillation-a-nationwide-real-world-cohort-study/]]></link>
			<title>Insomnia and the Risk of Atrial Fibrillation: A Nationwide, Real-World Cohort Study.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/timing-of-remdesivir-initiation-and-clinical-outcomes-in-hospitalized-patients-with-covid-19-who-are-at-high-risk-of-disease-progression-in-japan-a-health-insurance-claims-database-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/timing-of-remdesivir-initiation-and-clinical-outcomes-in-hospitalized-patients-with-covid-19-who-are-at-high-risk-of-disease-progression-in-japan-a-health-insurance-claims-database-study/]]></link>
			<title>Timing of Remdesivir Initiation and Clinical Outcomes in Hospitalized Patients with COVID-19 Who Are at High Risk of Disease Progression in Japan: A Health Insurance Claims Database Study.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/real-world-perioperative-systemic-treatment-patterns-and-outcomes-in-patients-with-urothelial-carcinoma-undergoing-radical-surgery/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/real-world-perioperative-systemic-treatment-patterns-and-outcomes-in-patients-with-urothelial-carcinoma-undergoing-radical-surgery/]]></link>
			<title>Real-world perioperative systemic treatment patterns and outcomes in patients with urothelial carcinoma undergoing radical surgery.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/adherence-to-single-inhaler-triple-therapies-in-middle-aged-patients-with-chronic-obstructive-pulmonary-disease-a-group-based-trajectory-analysis/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/adherence-to-single-inhaler-triple-therapies-in-middle-aged-patients-with-chronic-obstructive-pulmonary-disease-a-group-based-trajectory-analysis/]]></link>
			<title>Adherence to single-inhaler triple therapies in middle-aged patients with chronic obstructive pulmonary disease: A group-based trajectory analysis.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/prediction-model-for-aortic-dissection-aortic-aneurysm-and-peripheral-artery-disease/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/prediction-model-for-aortic-dissection-aortic-aneurysm-and-peripheral-artery-disease/]]></link>
			<title>Prediction model for aortic dissection, aortic aneurysm, and peripheral artery disease.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/discontinuation-of-glucagon-like-peptide-1-receptor-agonists-after-bowel-obstruction-or-ileus-a-nationwide-real-world-database-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/discontinuation-of-glucagon-like-peptide-1-receptor-agonists-after-bowel-obstruction-or-ileus-a-nationwide-real-world-database-study/]]></link>
			<title>Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists After Bowel Obstruction or Ileus: A Nationwide, Real-World, Database Study.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/adherence-to-lama-laba-therapies-in-middle-aged-patients-with-chronic-obstructive-pulmonary-disease-a-group-based-trajectory-analysis-2/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/adherence-to-lama-laba-therapies-in-middle-aged-patients-with-chronic-obstructive-pulmonary-disease-a-group-based-trajectory-analysis-2/]]></link>
			<title>Adherence to LAMA/LABA therapies in middle-aged patients with chronic obstructive pulmonary disease: A group-based trajectory analysis.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/cardiac-monitoring-in-adolescent-and-young-adult-cancer-patients-treated-with-anthracyclines-a-longitudinal-descriptive-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/cardiac-monitoring-in-adolescent-and-young-adult-cancer-patients-treated-with-anthracyclines-a-longitudinal-descriptive-study/]]></link>
			<title>Cardiac monitoring in adolescent and young adult cancer patients treated with anthracyclines: a longitudinal descriptive study.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/trends-in-anti-osteoporosis-pharmacotherapy-and-pharmacological-initiation-for-secondary-fracture-prevention-in-japan-2017-2023/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/trends-in-anti-osteoporosis-pharmacotherapy-and-pharmacological-initiation-for-secondary-fracture-prevention-in-japan-2017-2023/]]></link>
			<title>Trends in anti-osteoporosis pharmacotherapy and pharmacological initiation for secondary fracture prevention in Japan, 2017-2023.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/gastrointestinal-adverse-reactions-and-metabolism-nutrition-disorders-associated-with-hypomethylating-agents-a-pharmacovigilance-study-with-exploratory-mechanistic-analysis/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/gastrointestinal-adverse-reactions-and-metabolism-nutrition-disorders-associated-with-hypomethylating-agents-a-pharmacovigilance-study-with-exploratory-mechanistic-analysis/]]></link>
			<title>Gastrointestinal adverse reactions and metabolism-nutrition disorders associated with hypomethylating agents: a pharmacovigilance study with exploratory mechanistic analysis.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/topical-cycling-and-systemic-eligibility-in-patients-with-psoriasis-in-japan/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/topical-cycling-and-systemic-eligibility-in-patients-with-psoriasis-in-japan/]]></link>
			<title>Topical Cycling and Systemic Eligibility in Patients With Psoriasis in Japan.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/dermatomyositis-predominates-among-checkpoint-inhibitor-associated-inflammatory-myositis-phenotypes-a-pharmacovigilance-disproportionality-analysis-identifies-a-class-wide-signal/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/dermatomyositis-predominates-among-checkpoint-inhibitor-associated-inflammatory-myositis-phenotypes-a-pharmacovigilance-disproportionality-analysis-identifies-a-class-wide-signal/]]></link>
			<title>Dermatomyositis predominates among checkpoint inhibitor-associated inflammatory myositis phenotypes: a pharmacovigilance disproportionality analysis identifies a class-wide signal.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/a-preliminary-study-on-the-efficacy-and-safety-of-a-novel-digital-therapeutic-device-a-randomized-clinical-trial-in-south-korean-pediatric-patients-with-attention-deficit-hyperactivity-disorder/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/a-preliminary-study-on-the-efficacy-and-safety-of-a-novel-digital-therapeutic-device-a-randomized-clinical-trial-in-south-korean-pediatric-patients-with-attention-deficit-hyperactivity-disorder/]]></link>
			<title>A Preliminary Study on the Efficacy and Safety of a Novel Digital Therapeutic Device: A Randomized Clinical Trial in South Korean Pediatric Patients With Attention-Deficit/Hyperactivity Disorder.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/acquired-haemophilia-a-and-covid-19-mrna-vaccine-tozinameran-analysis-of-cases-registered-in-the-french-pharmacovigilance-database/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/acquired-haemophilia-a-and-covid-19-mrna-vaccine-tozinameran-analysis-of-cases-registered-in-the-french-pharmacovigilance-database/]]></link>
			<title>Acquired Haemophilia A and COVID-19 mRNA Vaccine Tozinameran: Analysis of Cases Registered in the French PharmacoVigilance Database.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/exercise-interventions-are-most-consistently-supported-for-depressive-disorders-an-umbrella-review-of-diagnosed-depressive-and-anxiety-disorders/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/exercise-interventions-are-most-consistently-supported-for-depressive-disorders-an-umbrella-review-of-diagnosed-depressive-and-anxiety-disorders/]]></link>
			<title>Exercise interventions are most consistently supported for depressive disorders: an umbrella review of diagnosed depressive and anxiety disorders.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/real-world-effectiveness-and-safety-of-ramipril-indapamide-combination-therapy-in-essential-hypertension-a-retrospective-study-on-uk-primary-care-records/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/real-world-effectiveness-and-safety-of-ramipril-indapamide-combination-therapy-in-essential-hypertension-a-retrospective-study-on-uk-primary-care-records/]]></link>
			<title>Real-World Effectiveness and Safety of Ramipril/Indapamide Combination Therapy in Essential Hypertension: A Retrospective Study on UK Primary Care Records.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/current-clinical-applications-and-clinical-evidence-of-bojungikki-tang-a-traditional-east-asian-multi-botanical-preparation-a-scoping-review/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/current-clinical-applications-and-clinical-evidence-of-bojungikki-tang-a-traditional-east-asian-multi-botanical-preparation-a-scoping-review/]]></link>
			<title>Current clinical applications and clinical evidence of Bojungikki-tang, a traditional East Asian multi-botanical preparation: a scoping review.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/hearing-loss-and-risk-of-major-osteoporotic-fracture-a-population-based-cohort-study-in-the-united-kingdom/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/hearing-loss-and-risk-of-major-osteoporotic-fracture-a-population-based-cohort-study-in-the-united-kingdom/]]></link>
			<title>Hearing loss and risk of major osteoporotic fracture: a population-based cohort study in the United Kingdom.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/defining-phenotypes-of-disease-severity-for-long-term-cardiovascular-renal-metabolic-and-mental-health-conditions-in-primary-care-electronic-health-records-a-mixed-methods-study-using-the-nominal/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/defining-phenotypes-of-disease-severity-for-long-term-cardiovascular-renal-metabolic-and-mental-health-conditions-in-primary-care-electronic-health-records-a-mixed-methods-study-using-the-nominal/]]></link>
			<title>Defining phenotypes of disease severity for long-term cardiovascular, renal, metabolic, and mental health conditions in primary care electronic health records: A mixed-methods study using the nominal group technique.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/child-body-mass-index-and-health-care-costs-in-england/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/child-body-mass-index-and-health-care-costs-in-england/]]></link>
			<title>Child Body Mass Index and Health Care Costs in England.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/blood-pressure-and-adverse-cardiovascular-outcomes-in-older-people-with-type-2-diabetes-and-chronic-kidney-disease-findings-based-on-the-clinical-practice-research-datalink-databases-in-england/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/blood-pressure-and-adverse-cardiovascular-outcomes-in-older-people-with-type-2-diabetes-and-chronic-kidney-disease-findings-based-on-the-clinical-practice-research-datalink-databases-in-england/]]></link>
			<title>Blood pressure and adverse cardiovascular outcomes in older people with type 2 diabetes and chronic kidney disease: Findings based on the Clinical Practice Research Datalink databases in England.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/use-of-levothyroxine-among-pregnant-women-with-subclinical-hypothyroidism-in-the-united-kingdom-a-population-based-assessment/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/use-of-levothyroxine-among-pregnant-women-with-subclinical-hypothyroidism-in-the-united-kingdom-a-population-based-assessment/]]></link>
			<title>Use of levothyroxine among pregnant women with subclinical hypothyroidism in the United Kingdom: A population-based assessment.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/use-of-5-alpha-reductase-inhibitors-and-risk-of-gastrointestinal-cancers-in-men-with-benign-prostatic-hyperplasia-a-population-based-cohort-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/use-of-5-alpha-reductase-inhibitors-and-risk-of-gastrointestinal-cancers-in-men-with-benign-prostatic-hyperplasia-a-population-based-cohort-study/]]></link>
			<title>Use of 5-alpha reductase inhibitors and risk of gastrointestinal cancers in men with benign prostatic hyperplasia: A population-based cohort study.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/examining-variations-in-the-prevalence-of-hazardous-opioid-prescribing-across-general-practices-in-england-a-cross-sectional-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/examining-variations-in-the-prevalence-of-hazardous-opioid-prescribing-across-general-practices-in-england-a-cross-sectional-study/]]></link>
			<title>Examining variations in the prevalence of hazardous opioid prescribing across general practices in England: a cross-sectional study.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:46 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/the-incidence-and-mortality-of-connective-tissue-diseases-a-population-level-cohort-study-in-england-from-2012-to-2023/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/the-incidence-and-mortality-of-connective-tissue-diseases-a-population-level-cohort-study-in-england-from-2012-to-2023/]]></link>
			<title>The incidence and mortality of connective tissue diseases: a population-level cohort study in England from 2012 to 2023.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:46 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/traumatic-brain-injury-and-risk-of-amyotrophic-lateral-sclerosis/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/traumatic-brain-injury-and-risk-of-amyotrophic-lateral-sclerosis/]]></link>
			<title>Traumatic Brain Injury and Risk of Amyotrophic Lateral Sclerosis.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:46 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/potential-impacts-of-adult-growth-hormone-deficiency-a-population-based-study-in-england/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/potential-impacts-of-adult-growth-hormone-deficiency-a-population-based-study-in-england/]]></link>
			<title>Potential impacts of adult growth hormone deficiency: a population-based study in England.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/a-letter-intervention-to-gps-practices-to-promoting-prescription-uptake-in-school-age-children-with-asthma-during-summer-holidays-trains-study-a-pragmatic-cluster-randomised-controlled-trial/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/a-letter-intervention-to-gps-practices-to-promoting-prescription-uptake-in-school-age-children-with-asthma-during-summer-holidays-trains-study-a-pragmatic-cluster-randomised-controlled-trial/]]></link>
			<title>A letter intervention to GPs practices to promoting prescription uptake in school-age children with asthma during summer holidays (TRAINS study): a pragmatic cluster randomised controlled trial.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/developing-and-validating-the-ce-mace-model-to-predict-one-year-major-adverse-cardiovascular-events-post-copd-exacerbation-using-routine-healthcare-data/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/developing-and-validating-the-ce-mace-model-to-predict-one-year-major-adverse-cardiovascular-events-post-copd-exacerbation-using-routine-healthcare-data/]]></link>
			<title>Developing and validating the CE-MACE model to predict 1-year major adverse cardiovascular events post-COPD exacerbation using routine healthcare data.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/evaluating-arrhythmia-risk-in-patients-with-chronic-obstructive-pulmonary-disease-treated-with-aclidinium-formoterol-fumarate-and-other-inhaled-bronchodilators-a-post-authorization-safety-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/evaluating-arrhythmia-risk-in-patients-with-chronic-obstructive-pulmonary-disease-treated-with-aclidinium-formoterol-fumarate-and-other-inhaled-bronchodilators-a-post-authorization-safety-study/]]></link>
			<title>Evaluating Arrhythmia Risk in Patients with Chronic Obstructive Pulmonary Disease Treated with Aclidinium/Formoterol Fumarate and Other Inhaled Bronchodilators: A Post-Authorization Safety Study.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/recurrent-intra-articular-corticosteroid-injections-in-osteoarthritis-the-rubicon-mixed-methods-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/recurrent-intra-articular-corticosteroid-injections-in-osteoarthritis-the-rubicon-mixed-methods-study/]]></link>
			<title>RecUrrent Intra-articular Corticosteroid injections in Osteoarthritis: the RUbICOn mixed-methods study.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/trends-in-mortality-and-major-adverse-cardiovascular-events-following-incident-acute-myocardial-infarction/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/trends-in-mortality-and-major-adverse-cardiovascular-events-following-incident-acute-myocardial-infarction/]]></link>
			<title>Trends in mortality and major adverse cardiovascular events following incident acute myocardial infarction.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/exploring-patient-perspectives-on-the-use-of-artificial-intelligence-to-inform-joint-decision-making-for-patients-with-multiple-conditions-in-primary-care-in-the-united-kingdom-qualitative-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/exploring-patient-perspectives-on-the-use-of-artificial-intelligence-to-inform-joint-decision-making-for-patients-with-multiple-conditions-in-primary-care-in-the-united-kingdom-qualitative-study/]]></link>
			<title>Exploring Patient Perspectives on the Use of Artificial Intelligence to Inform Joint Decision-Making for Patients With Multiple Conditions in Primary Care in the United Kingdom: Qualitative Study.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/how-does-diagnostic-subtype-affect-the-quality-of-primary-care-for-people-with-dementia-a-retrospective-cohort-study-in-1490-english-general-practices/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/how-does-diagnostic-subtype-affect-the-quality-of-primary-care-for-people-with-dementia-a-retrospective-cohort-study-in-1490-english-general-practices/]]></link>
			<title>How does diagnostic subtype affect the quality of primary care for people with dementia? A retrospective cohort study in 1490 English general practices.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/the-incidence-mortality-and-complications-of-systemic-lupus-erythematosus-a-population-level-cohort-study-from-2012-to-2023/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/the-incidence-mortality-and-complications-of-systemic-lupus-erythematosus-a-population-level-cohort-study-from-2012-to-2023/]]></link>
			<title>The incidence, mortality and complications of systemic lupus erythematosus: a population-level cohort study from 2012 to 2023.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/impact-of-depression-on-treatment-progression-in-type-2-diabetes-a-uk-retrospective-cohort-study-using-the-clinical-practice-research-datalink-aurum-database/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/impact-of-depression-on-treatment-progression-in-type-2-diabetes-a-uk-retrospective-cohort-study-using-the-clinical-practice-research-datalink-aurum-database/]]></link>
			<title>Impact of depression on treatment progression in type 2 diabetes: A UK retrospective cohort study using the Clinical Practice Research Datalink Aurum database.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:43 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/secular-trends-of-incidence-and-prevalence-of-parkinsonism-subtypes-a-cohort-study-in-the-united-kingdom/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/secular-trends-of-incidence-and-prevalence-of-parkinsonism-subtypes-a-cohort-study-in-the-united-kingdom/]]></link>
			<title>Secular trends of incidence and prevalence of Parkinsonism subtypes: a cohort study in the United Kingdom.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:43 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/association-between-gabapentinoid-treatment-concurrent-use-with-opioid-or-benzodiazepine-and-the-risk-of-drug-poisoning-a-self-controlled-case-series-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/association-between-gabapentinoid-treatment-concurrent-use-with-opioid-or-benzodiazepine-and-the-risk-of-drug-poisoning-a-self-controlled-case-series-study/]]></link>
			<title>Association between gabapentinoid treatment, concurrent use with opioid or benzodiazepine and the risk of drug poisoning: A self-controlled case series study.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:43 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/diagnosis-of-inflammatory-bowel-disease-following-symptomatic-faecal-immunochemical-testing-a-population-based-cohort-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/diagnosis-of-inflammatory-bowel-disease-following-symptomatic-faecal-immunochemical-testing-a-population-based-cohort-study/]]></link>
			<title>Diagnosis of inflammatory bowel disease after symptomatic faecal immunochemical testing: population-based cohort study.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/palliative-and-end-of-life-care-in-people-with-and-without-intellectual-disabilities-in-primary-care-identification-survival-time-and-healthcare-utilization/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/palliative-and-end-of-life-care-in-people-with-and-without-intellectual-disabilities-in-primary-care-identification-survival-time-and-healthcare-utilization/]]></link>
			<title>Palliative and end-of-life care in people with and without intellectual disabilities in primary care: identification, survival time, and healthcare utilization.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/bowel-cancer-care-in-individuals-with-an-intellectual-disability-a-population-based-cohort-study-of-symptoms-diagnostic-pathways-treatment-and-survival-2/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/bowel-cancer-care-in-individuals-with-an-intellectual-disability-a-population-based-cohort-study-of-symptoms-diagnostic-pathways-treatment-and-survival-2/]]></link>
			<title>Bowel cancer care in individuals with an intellectual disability: a population-based cohort study of symptoms, diagnostic pathways, treatment and survival.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/comparative-effectiveness-and-safety-of-fluticasone-umeclidinium-vilanterol-and-beclomethasone-glycopyrronium-formoterol-single-inhaler-triple-therapies-for-copd-real-world-observational-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/comparative-effectiveness-and-safety-of-fluticasone-umeclidinium-vilanterol-and-beclomethasone-glycopyrronium-formoterol-single-inhaler-triple-therapies-for-copd-real-world-observational-study/]]></link>
			<title>Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study.</title>
			<pubDate><![CDATA[Sun, 26 Jul 2026 13:54:41 +0000]]></pubDate>
		</item>
				</channel>
</rss>
